Table 2.
Summary of adverse events
| Adverse events | CCR (n = 96) | RT (n = 96) |
|---|---|---|
| G3/4 (≥G3) (%) | G3/4 (≥G3) (%) | |
| Leukopenia | 8/3 (11%) | 4/3 (7%) |
| Thrombocytopenia | 2/0 (2%) | 0/0 (0%) |
| Nausea | 4/1 (5%) | 2/0 (2%) |
| Diarrhea | 11/0 (11%) | 4/0 (4%) |
| Anaemia | 3/0 (3%) | 1/0 (1%) |
Summary of adverse events
| Adverse events | CCR (n = 96) | RT (n = 96) |
|---|---|---|
| G3/4 (≥G3) (%) | G3/4 (≥G3) (%) | |
| Leukopenia | 8/3 (11%) | 4/3 (7%) |
| Thrombocytopenia | 2/0 (2%) | 0/0 (0%) |
| Nausea | 4/1 (5%) | 2/0 (2%) |
| Diarrhea | 11/0 (11%) | 4/0 (4%) |
| Anaemia | 3/0 (3%) | 1/0 (1%) |